In English
NIDA

Ciencia de la adicción

A Genetic Nexus of Obesity and Smoking

Research shows that some gene variants that influence body mass index also shape smoking behaviors.

Student-Scientists Present Award-Winning Research at NIDA

Four high school students were honored for their work regarding e-cigarettes, the GABAA neuroreceptor, and adolescent multitasking.

Dr. Antonello Bonci Q & A: Lighting Up the Brain To Shut Down Cocaine Seeking

The Scientific Director of NIDA’s Intramural Research Program talks about switching off animals’ compulsive cocaine seeking by optogenetically activating the prefrontal cortex, and the implications of this work for people. In an accompanying podcast, Dr. Bonci walks viewers through experiments that showed that prefrontal cortex activity levels may constitute a simple switch controlling whether or not animals compulsively seek cocaine.

CPDD conference features NIDA Director Dr. Nora Volkow as well as Media Forum

Dr. Nora Volkow, Director of the National Institute on Drug Abuse (NIDA), will deliver a keynote address on the state of addiction research at the annual meeting of the College on Problems of Drug Dependence (CPDD) in San Juan, Puerto Rico on June 15.


Gene Variants Reduce Opioid Risks

Two recent studies suggest that genotyping may enable clinicians to base therapies on individual patients’ potential responsiveness to opioid drugs’ therapeutic effects and vulnerability to their harmful effects.

New Insight Into How Cues Cause Relapse to Cocaine

A brain response occurs in the nucleus accumbens when rats encounter a cue that they associate with previous cocaine self-administration, but not a cue associated with a pleasurable non-drug experience. Moreover, the response correlates in time and intensity with the animals’ cue-induced relapse to cocaine-seeking.

Dr. Joni Rutter Q&A: How Basic Science Is Tackling Addiction

One of NIDA’s goals is to try to understand the individual differences that contribute to whether or not someone who takes a drug will become addicted to it. Dr. Rutter’s research focuses on three types of differences: Environmental, developmental, and genetic and epigenetic.

UNODC Recommends Treating Addiction as Health, Not Legal, Issue

Earlier this month I went to Vienna for the 57th session of the Commission on Narcotic Drugs (CND), part of the United Nations Office on Drugs and Crime (UNODC). There I chaired a working group that presented a set of recommendations to the CND concerning the most appropriate, scientifically informed way to approach the problem of substance use disorders: as a medical, not a legal, issue.

Páginas

Take the IQ Challenge en Español!